RE: COPD v COVID (2)9 Aug 2020 22:46
TrinityMan
Synairgen has been a fantastic experience. I agree there has and continues to be some outstanding knowledge and posters. Back in Feb / March we all researched Synairgen and similar companies and reviewed research from across the world. As we built our knowledge pool the a picture developed and I think we all added more than normal into the SNG pot. I remember many doubters and trolls tried to weaken our mindset. We faced a huge headwind of three sellers and a placing. In that time the share price reached 70p and then dropped to a low around 32p. What a ride.
It was the team effort that kept me focused, that and the outstanding team at Synairgen. As world trials using Interferons increased and results started to appear more
And more positive, our belief increased and so did the displeasure of the trolls! Then mad Monday happens, I think I will remember that day until I die. 7am RNS the headline 3 statements were MASSIVE! That day made the last 8 years of AIM PAIN worth it.
Looking forward I will again show some caution and warn anything can happen this is AIM. However I, like many others, believe this is worth a minimum £1billion at take over. £6.33 per share. I expect to see COPD results soon. Let’s not get disappointed if they don’t land tomorrow, as RM confirmed there are multiple data points against multiple virus. FDA and MHRA emergency applications must also being expedited. Let’s also not forget our friends in Auss. LOXL2 has huge potential still and news is due there as well.
Like most I have sold some of my holding. However I had to keep some skin in the game and I believe we won’t be disappointed.
Sleep well all and here is to a fantastic month for all still invested.